Lipocine Inc.

NASDAQ: LPCN · Real-Time Price · USD
3.03
-0.01 (-0.33%)
At close: Aug 15, 2025, 3:59 PM
3.04
0.33%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lipocine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
622.85K 93.86K 3.49M n/a 89.56K 7.62M 216.19K -3.12M n/a 54.99K n/a n/a 500K n/a 16.09M 54.99K n/a n/a
Cost of Revenue
2.14M 15.57K 15.57K 8.51K 1.87M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-1.51M 93.86K 3.49M -5.48M -1.79M 7.62M 216.19K -3.12M n/a 54.99K n/a n/a 500K n/a 16.09M 54.99K n/a n/a
Operating Income
-2.4M -2.09M 1.55M -2.63M -3.29M 3.22M -2.59M -7.04M -3.96M -4.34M -2.56M -2.9M -3.53M -3.13M 12.78M -3.53M -2.99M -3.11M
Interest Income
198.64K 225.51K 233.12K 273.57K 308.85K 331.36K 299.38K 317.57K 379.52K 370.47K 297.16K 163.97K 69.88K 22.05K 22.44K 17.26K 17.34K 10.65K
Pretax Income
-2.21M -1.86M 1.78M -2.22M -3.07M 3.51M -2.28M -6.65M -3.55M -3.87M -2.23M -2.41M -2.63M -3.49M 12.62M -3.08M -6.81M -3.37M
Net Income
-2.21M -1.86M 1.78M -2.22M -3.07M 3.51M -2.28M -6.65M -3.55M -3.87M -2.23M -2.41M -2.63M -3.49M 12.62M -3.08M -6.81M -3.37M
Selling & General & Admin
890.43K 1.12M 873.05K 1.05M 1.51M 1.58M 1.13M 1.04M 1.44M 1.29M 890.34K 798.94K 1.13M 1.24M 1.05M 1.22M 1.53M 1.53M
Research & Development
n/a 1.06M 1.07M 1.59M 1.87M 2.82M 1.67M 2.88M 2.52M 3.11M 1.67M 2.1M 2.9M 1.89M 2.25M 2.37M 1.46M 1.58M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
890.43K 2.18M 1.95M 2.63M 3.47M 4.43M 2.8M 3.85M 3.93M 4.3M 2.53M 2.57M 3.19M 3.51M 3.45M 3.11M 6.77M 3.31M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 7.57K n/a 32.05K 44.84K 57.43K 68.97K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.03M 2.18M 1.95M 2.63M 3.47M 4.43M 2.8M 3.85M 3.93M 4.3M 2.53M 2.57M 3.19M 3.51M 3.45M 3.11M 6.77M 3.31M
Income Tax Expense
n/a 200.00 n/a n/a 481.00 200.00 555.00 n/a n/a 200.00 481.00 n/a n/a 200.00 n/a n/a n/a 200.00
Shares Outstanding (Basic)
5.35M 5.35M 5.34M 5.35M 5.34M 5.32M 5.29M 5.23M 5.19M 5.11M 5.16M 4.62M 4.31M 5.19M 5.19M 4.53M 5.07M 4.82M
Shares Outstanding (Diluted)
5.35M 5.35M 5.42M 5.35M 5.34M 5.36M 5.32M 5.29M 5.23M 5.23M 5.23M 5.25M 5.26M 5.19M 5.23M 5.23M 5.23M 4.82M
EPS (Basic)
-0.41 -0.35 0.33 -0.41 -0.57 0.66 -0.43 -1.27 -0.68 -0.76 -0.43 -0.52 -0.5 -0.67 2.43 -0.59 -1.31 -0.7
EPS (Diluted)
-0.41 -0.35 0.32 -0.41 -0.57 0.66 -0.43 -1.26 -0.68 -0.74 -0.43 -0.46 -0.61 -0.67 2.43 -0.68 -1.34 -0.7
EBITDA
-2.39M -2.07M 1.56M -2.62M -3.28M 3.23M -2.27M -7.04M -3.95M -4.33M -2.23M -2.41M -2.62M -3.47M 12.78M -3.04M -6.75M -3.3M
EBIT
-2.4M -2.09M 1.55M -2.63M -3.29M 3.22M -2.28M -7.04M -3.96M -4.34M -2.23M -2.41M -2.62M -3.47M 12.78M -3.04M -6.75M -3.3M
Depreciation & Amortization
16.11K 15.57K 15.57K 8.51K 8.51K 8.51K 8K 7.75K 8.09K 4.82K 2.58K 2.58K 2.58K 1.72K 95.00 889.00 889.00 889.00